Thursday, February 9, 2023

Latest:

Men 60 and older with certain risk factors should get screened for life-threatening heart condition
Entanglement within a (transcriptional) bubble explains finely tuned regulation of gene expression
Philosophy, an ancient practice with modern appeal? The role of “big” questions in medical decision-making
Sensitive, rapid tests help to ID estrogen-disrupting chemicals in the environment
Why women with heart issues are undertreated and have worse outcomes than men

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Acute Lymphoblastic Leukemia

From The Labs

Applying basic science helps predict poor treatment outcomes in ALL

November 21, 2019November 21, 2019Acute Lymphoblastic Leukemia, ALL, carbon metabolism, metabolome, Pediatric Cancer, prognosis, Research

The survival of patients with pediatric acute lymphoblastic leukemia (ALL) has significantly improved in the last several decades, but there is still a group of

From The Labs

Exploring the risk of ALL in children with Down syndrome

September 24, 2019September 24, 2019Acute Lymphoblastic Leukemia, ALL, CDKN2A gene, Childhood leukemia, Down syndrome, IKZF1 gene, Research

Acute Lymphoblastic Leukemia (ALL) is the most common childhood cancer. Children with trisomy 21 (Down syndrome) are 10 to 20 times more likely to develop ALL

From the Labs: Adult-born neurons made the cover